# Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

> **NCT00182429** · PHASE3 · COMPLETED · sponsor: **McMaster University** · enrollment: 100 (—)

## Conditions studied

- Clostridium Enterocolitis
- Antibiotic-Associated Diarrhea
- Pseudomembranous Colitis
- Pseudomembranous Enterocolitis
- Pseudomembranous Enteritis

## Interventions

- **DRUG:** Metronidazole and Rifampin

## Key facts

- **NCT ID:** NCT00182429
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2005-04-30
- **Final completion:** 2005-12-31
- **Target enrollment:** 100 (—)
- **Last updated:** 2018-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00182429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00182429, "Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00182429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*